Actively Recruiting
The Effect of Immersive Virtual Reality and Relaxing Videos on Lung Cancer Patients
Led by Hacettepe University · Updated on 2025-03-13
90
Participants Needed
1
Research Sites
69 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Lung cancer is one of the types of cancer with a high incidence and mortality rate in the world and in our country. Frequently used protocols in the chemotherapy treatment of lung cancer are the Platine-based drugs. The main side effects of this chemotherapy protocols are nausea, vomiting, neutropenia and fatigue. The side effects of cancer and chemotherapy cause patients to experience distress and their quality of life is adversely affected. Some non-pharmacological methods such as meditation, breathing exercises, and massage can be used to manage the symptoms experienced by patients due to chemotherapy for supportive care. One of these methods is the virtual reality applications. In addition, audio-visual (video) therapy methods are other methods that can be used in the symptom management of these patients. In this study, the effect of interactive/imersive virtual reality intervention and relaxant video intervention on symptom severity, distress level and quality of life of patients diagnosed with lung cancer will be evaluated. Patients will be assigned to 3 groups: virtual reality intervention group (VR), relaxant video application group (RV) and control group (CG) by stratified randomization according to the disease stage and dryg type. During the chemotherapy treatment, the patients will take interactive/immersibe virtual reality (VR group) or relaxant video application (RV group) consisting of nature-themed scenarios. The interventions will be done 2 times and about 20 minutes in the first day of each chemotherapy cycles, in total 2 cycles. The control group will receive routine nursing care. Research data will be collected at different intervals during the chemotherapy course with the Patient Information Form (only once), the Edmonton Symptom Diagnosis Scale, the NCCN Distress Thermometer, the European Cancer Treatment and Organization Committee Quality of Life Scale and the Patient Follow-up Form and will be analyzed with the IBM SPSS v.23 program.
CONDITIONS
Official Title
The Effect of Immersive Virtual Reality and Relaxing Videos on Lung Cancer Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Are over 18 years old
- Diagnosed with lung cancer
- Will receive chemotherapy for the first time
- Will receive at least 2 cycles of chemotherapy treatment
- Agree to participate in the study
You will not qualify if you...
- Having a cognitive and psychiatric disorder or diagnosis
- Having brain metastasis or chronic disease related to the head or brain region
- Having vision or hearing problems
- Having epilepsy, vertigo, chronic severe headache, or dizziness problems
- Having a history of virtual reality, simulator, or motion sickness
- Having or declaring open area, underwater, or specific animal phobia
- Do not agree to participate in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hacettepe University
Ankara, Altındağ, Turkey (Türkiye), 06230
Actively Recruiting
Research Team
K
Kadir BAYSOY, PhD (c)
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here